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original article

An Evaluation of Food as a Potential Source for Clostridium difﬁcile
Acquisition in Hospitalized Patients
Jennie H. Kwon, MSCI;1 Cristina Lanzas, DVM, PhD;2 Kimberly A. Reske, MPH;1 Tiffany Hink, BS;1 Sondra M. Seiler, BS;1
Kerry M. Bommarito, PhD;1 Carey-Ann D. Burnham, PhD;3 Erik R. Dubberke, MD, MSPH1

objective. To determine whether Clostridium difﬁcile is present in the food of hospitalized patients and to estimate the risk of subsequent
colonization associated with C. difﬁcile in food.
methods. This was a prospective cohort study of inpatients at a university-afﬁliated tertiary care center, May 9, 2011–July 12, 2012.
Enrolled patients submitted a portion of food from each meal. Patient stool specimens and/or rectal swabs were collected at enrollment, every
3 days thereafter, and at discharge, and were cultured for C. difﬁcile. Clinical data were reviewed for evidence of infection due to C. difﬁcile.
A stochastic, discrete event model was developed to predict exposure to C. difﬁcile from food, and the estimated number of new colonization
events from food exposures per 1,000 admissions was determined.
results. A total of 149 patients were enrolled and 910 food specimens were obtained. Two food specimens from 2 patients were positive for
C. difﬁcile (0.2% of food samples; 1.3% of patients). Neither of the 2 patients was colonized at baseline with C. difﬁcile. Discharge colonization
status was available for 1 of the 2 patients and was negative. Neither was diagnosed with C. difﬁcile infection while hospitalized or during the year
before or after study enrollment. Stochastic modeling indicated contaminated hospital food would be responsible for less than 1 newly colonized
patient per 1,000 hospital admissions.
conclusions. The recovery of C. difﬁcile from the food of hospitalized patients was rare. Modeling suggests hospital food is unlikely to be a
source of C. difﬁcile acquisition.
Infect Control Hosp Epidemiol 2 0 16 ;3 7 :1 40 1 – 14 07

Clostridium difﬁcile infection (CDI) is the most common
healthcare-associated infection in the United States and is
associated with signiﬁcant patient morbidity, mortality, and
high attributable acute care hospital costs.1–3 Given the
continued high incidence and severity of clinical outcomes
associated with CDI, measures to prevent CDI are an area of
ongoing interest. Current strategies for CDI prevention are
focused on interrupting the cycle of transmission from
individuals with CDI; however, it is important to evaluate
other potential modes for C. difﬁcile acquisition.
Although CDI is primarily associated with healthcare facilities, the precise source of C. difﬁcile exposure is unknown.
Recent studies have found that only 15%–25% of CDI cases
could be attributed to ward-based or patient-to-patient transmission, indicating that there may be other sources of C. difﬁcile
acquisition in the hospital.4,5 A potential reservoir and source
for C. difﬁcile acquisition is the food of hospitalized patients.
C. difﬁcile has been isolated from retail foods worldwide,
including ground meats, poultry, and vegetables.6–17 The spores

of C. difﬁcile are heat-resistant and thus may have the potential
to survive cooking temperatures.10 Given the presence of
C. difﬁcile in food and its heat-resistant qualities, it is theoretically possible that hospitalized patients could be exposed to
C. difﬁcile from their food. We conducted a prospective cohort
study with the objectives of determining whether C. difﬁcile was
present in the food of hospitalized patients and of estimating the
risk of colonization associated with the presence of C. difﬁcile in
the food of hospitalized patients.

methods
Setting
This prospective cohort study was conducted at Barnes-Jewish
Hospital (BJH), a 1,250-bed tertiary care center in St. Louis,
MO, from May 9, 2011, through July 12, 2012, in conjunction
with a study of C. difﬁcile colonization in hospitalized
patients.18,19 The study was approved by the Washington
University Human Research Protection Ofﬁce.

Afﬁliations: 1. Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri; 2. Department of Population Health and
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Subjects
Subjects at least 18 years old admitted to the medical and
surgical wards with a projected length of stay (LOS) of at least
3 days and no diarrhea were invited to participate; all provided
written, informed consent.

binary toxin genes (cdtA/cdtB) by multiplex polymerase chain
reaction as previously described.18 Isolates were also
characterized by polymerase chain reaction ribotyping for
strain comparison.23
Model Overview

Data Sources and Statistical Analyses
Data collected included demographic characteristics, comorbidities, and CDI diagnoses from 1 year prior to enrollment to
1 year after enrollment. Data sources included patient
interviews, medical chart review, and Medical Informatics
queries. Data analyses were descriptive. SPSS, version 21
(IBM), was used. The model was implemented in NetLogo,
version 5.1. R (R Foundation for Statistical Computing) was
used for model parameterization and output analysis.
Specimen Collection
Stool or rectal swab specimens were collected from patients upon
study enrollment, every 3 days, and at discharge. Rectal swab
samples (ESwab; Becton, Dickinson) were obtained from patients
unable to provide a stool specimen within 48 hours of admission
or 24 hours of a postadmission specimen collection time.20–22
Each patient was provided with a cooler and 4 sterile
specimen cups labeled breakfast, lunch, supper, or snack.
Patients were instructed to place a piece of food from everything they ate into the corresponding container. If they did not
eat a particular meal, no food was collected. As patients placed
all components of their meal into the same container, there
were multiple types of food per container.
Food specimens were transported to the laboratory and
frozen at −30°C. Prior to culture, food specimens were thawed
and the food types were documented. The food specimen was
combined with 10 mL of sterile water and homogenized for
approximately 1 minute.
Microbiological Analysis
Next, 1 mL of food homogenate was added to cycloserinecefoxitin mannitol broth with taurocholate, lysozyme, and
cysteine (CCMB-TAL; Anaerobe Systems), and the broth was
subcultured to pre-reduced blood agar (Becton, Dickinson) as
previously described.20 C. difﬁcile in food was quantiﬁed by
weighing initial specimens, processing via heat shock, plating
onto a pre-reduced blood agar plate, then streaking for isolation. Colonies per gram of food were calculated. Additionally,
food was diluted in CCMB-TAL broth in a series of ﬁve 10-fold
dilutions to approximate the burden of C. difﬁcile. C. difﬁcile
negative and positive controls were included with every set of
cultures to monitor for contamination. Ribotyping was
performed on all C. difﬁcile isolates as previously described.23
Stool and rectal swabs were cultured for C. difﬁcile using
CCMB-TAL according to methods previously published.20
Isolates were evaluated for the presence of tcdA, tcdB, and

To estimate the risk of C. difﬁcile acquisition associated with
exposure to C. difﬁcile-contaminated food during a hospital
stay, we developed a stochastic, individual-based model that
simulated the ﬂow of patients admitted to BJH, antimicrobial
exposures, number of meals eaten per day, and concentration
of C. difﬁcile in food (Figure 1). A formal description of the
model, code, and parameters is available at http://www.
lanzaslab.org/research/cdifﬁcile#food. The hospital model
simulated the 171 BJH general medicine hospital ward beds.
Each patient was followed from admission to discharge.
On admission, each patient was assigned a LOS. LOS depended
on whether the patient received antibiotic treatment based on
the distribution of LOS from 11,046 admissions from these
wards to several distributions using maximum likelihood
methods.24 On the basis of these data, antibiotic use was used
as a marker for longer LOS. Antibiotic use was also a marker
for susceptibility to C. difﬁcile colonization. The log-normal
distribution, which provided the best ﬁt, was used to parameterize LOS (Table 1).
The number of meals consumed by a patient daily and the
probability that a meal was contaminated were based on this
study’s results (Table 1). A Poisson log-normal distribution
was used to simulate the number of spores per contaminated
meal. This distribution is often used to describe microbial
counts.25 The parameters of the distribution were chosen to
generate a mean number of spores of approximately 10
colony-forming units/gm because this was the limit of detection of the culture methods. Data from a clinical trial in which
healthy adults received escalating doses of nontoxigenic
C. difﬁcile spores were used to estimate the probability of
C. difﬁcile colonization upon dose exposure.26 We used logistic
regression to model the data from study subjects in cohort
Number of consumed
meals

Probability of meal
contamination
Cumulative dose during
hospital stay *

Risk of colonization

Concentration of spores in
a contaminated meal

Length of hospital stay

Antibiotic use

ﬁgure 1. Exposure assessment in study of Clostridium difﬁcile in
the food of hospitalized patients. *Cumulative dose calculated by
total number of spores present in all contaminated meals eaten in a
hospital stay.
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4 who received 5 days of pretreatment with oral vancomycin
before receiving a daily dose of 1 × 104, 1 × 106, or 1 × 108
spores for 14 days. Because of the repeated measurements on
the same subjects, the binary correlated data were analyzed by
means of the generalized estimating equation27 as implemented in package geepack in R.28
The model was iterated 5,000 times to assure output
convergence. Each iteration simulated the patients’ admissions
to the wards for 1 year. In each iteration, model inputs
described as probability distributions were sampled and fed to
the model. The model outcomes were the number of patients
exposed to C. difﬁcile through food and the number of colonization events due to food exposure per 1,000 admissions.

results
Enrollment and Demographic Characteristics
A total of 149 patients were enrolled, and food specimens from
910 meals were obtained and cultured for C. difﬁcile. Patient
characteristics are in Table 2. Most patients had healthcare
exposures within the previous 90 days (136 [91%]), but only
2 patients had a history of CDI within the previous year
(none within 60 days prior to enrollment).

Food Cultures
Toxigenic C. difﬁcile was recovered from 2 food specimens
from 2 separate patients, representing 0.2% of food cultures
and 1.3% of patients (Table 3). The food items that tested
positive were a gelatin dessert (ribotype 001) and a sample
consisting of vegetables/bread/grains (ribotype 027). The
concentration of C. difﬁcile spores recovered from the positive
food samples was less than or equal to 10 colony-forming
units/mL. C. difﬁcile was successfully recovered from all positive controls, and there was no growth in any of the negative
controls.

table 1.
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C. difﬁcile Colonization and CDI
Neither of the 2 patients exposed to C. difﬁcile in food was
colonized at baseline with C. difﬁcile. A discharge stool specimen was available for 1 of the 2 patients and was negative.
Neither was diagnosed with CDI during their hospitalization
or during the year before or after study enrollment. No
patients in the study developed CDI within a year of discharge.

Exposure Modeling
A summary of the functions and probability distributions for
the exposure model are detailed in Table 1. On 44.1% of days,
no meals were eaten; on 17.5% of days 1 meal was eaten; on
26.4% of days 2 meals were eaten; on 11.2% of days 3 meals
were eaten; and on 0.8% of days 4 meals were eaten. Reasons
for missing meals were variable but included instructions to
take nothing by mouth in preparation for an upcoming procedure(s) or lack of appetite. The mean number of patients
who were exposed to C. difﬁcile through food was 12.70 per
1,000 admissions (95% CI, 12.542–12.858). The minimum
and maximum simulated values were 2.34 and 25.85 exposed
patients per 1,000 admissions, respectively (Figure 2). The
mean number of predicted colonization events was 0.609 per
1,000 admissions (95% CI, 0.600–0.618), and the median
number was 0.57. The minimum and maximum simulated
colonization events were 0.04 and 1.73 per 1,000 admissions,
respectively (Figure 2).
Both the predicted number of exposed and the predicted
number of colonized patients were highly inﬂuenced by the
probability of meal contamination (Figure 3). A 0.1% increase
in the probability of meal contamination resulted in an
increase of 5.5 exposures and 0.26 colonization events per
1,000 admissions (Figure 3). Overall, the simulated number of
spores in contaminated food was low, reﬂecting the low counts
recovered from hospital food. As a result, on average fewer
than 5% of the patients exposed to C. difﬁcile became colonized. Antibiotic prescription probability had a marginal effect

Summary of Functions and Probability Distributions for the Exposure Model

Description

Functions and probability distributions

Antibiotic prescription probability
Distribution of length of stay for patients who do not receive antibiotic
Distribution of length of stay for patients who receive antibiotic
N of meals (X) received by a patient daily

Uniform (0.3, 0.7)
Log-normal (0.84, 0.77)
Log-normal (1.54, 0.87)
P(X = 0) = 0.441, P(X = 1) = 0.175, P(X = 2)
= 0.264, P(X = 3) = 0.112, P(X = 4) = 0.008
Uniform (0.0005, 0.0035)
Poisson-lognormal (2, 0.8)
e3:073 + 0:539 log ðdose + 1Þ
1 + e3:073 + 0:539 log ðdose + 1Þ

Probability that a meal is contaminated with Clostridium difﬁcile spores
Distribution of the number of spores found on a contaminated meal
Relationship between cumulative dose in a hospital stay and probability of colonization
NOTE. The parameters needed to characterize

the probability distributions are indicated between brackets. For the uniform distribution (a,b): a is
the minimum value and b is the maximum value. For the log-normal and Poisson-lognormal distributions (µ, σ): µ is the log mean and σ is the
log standard deviation.
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table 2. Characteristics of 149 Patients in Study of Clostridium
difﬁcile in the Food of Hospitalized Patients

table 3. Types of Food Positive for Clostridium difﬁcile, by Food
Type, for 910 Meals

Variable

Food item

Value

Total

C. difﬁcile, n (%)

308
142
179
455
1
210
376
200

0
0
0
1 (<1)a
0
0
1 (<1)a
1 (1)c

Age, median (range), y
55 (23–90)
Length of stay, median (range), d
4.0 (0.4–292)
Female sex
80 (54)
Nonwhite race
43 (29)
Healthcare worker
20 (13)
Lives with a healthcare worker
19 (13)
Spends ≥2 hours/week visiting a healthcare facility
16 (11)
Admitted to medicine service
145 (97)
Admitted from
Home
99 (66)
Healthcare facility
50 (34)
Reason for admission
Infection
45 (30)
Exacerbation of chronic condition
54 (36)
Elective surgery
2 (1)
New medical or surgical problem
48 (32)
Any healthcare exposures in previous 90 days
136 (91)
Diabetes mellitus
58 (39)
Congestive heart failure
27 (18)
Liver disease
28 (19)
Chronic renal insufﬁciency
17 (11)
Chronic lung disease
25 (17)
Human immunodeﬁciency virus
3 (2)
Solid organ transplant
8 (5)
Stem cell transplant
0
Solid malignant tumor
24 (16)
Hematologic malignant tumor
2 (1)
Other immunocompromised
20 (13)
Inﬂammatory bowel disease
5 (3)
Surgery in previous 90 days
15 (10)
Upper endoscopy performed during
9 (6)
hospitalization
Lower endoscopy performed during
8 (5)
hospitalization
History of CDI in the year before enrollment
2 (1)
CDI diagnosis within 1 year after enrollment
0
Colonized with C. difﬁcile on admission
34 (23)
Colonized with C. difﬁcile on dischargea
35/141 (25)

Meat
Poultry
Fruit
Vegetables
Nuts
Dairy/eggs
Bread/grains
Otherb

NOTE. Data are no. (%) of patients unless otherwise indicated. CDI,
C. difﬁcile infection.
a
Discharge colonization status was unknown for 8 patients (5%).

ﬁgure 2. Histograms for the simulated number of patients
exposed to Clostridium difﬁcile in food and colonization events due
to exposure to C. difﬁcile spores in food. Counts are the number of
exposed and colonized patients in each histogram bar.

on the number of predicted exposed and colonized patients
compared with probability of meal contamination (Figure 3).

theoretically hundreds of hospitalized patients could be
exposed to C. difﬁcile from food and develop CDI every year at
BJH, which in 2014 alone had more than 53,300 inpatient
admissions. Thus, our objective was to model the likelihood of
C. difﬁcile acquisition from food in the hospital setting. Using a
similar modeling framework based on BJH data, we previously
predicted that on average there were approximately 100 new
colonization events per 1,000 admissions.29 In this study, we
found that at less than 1 new colonization event per 1,000
admissions, C. difﬁcile acquisition linked to contaminated food
was likely uncommon. The results of the modeling indicate

d i s c u s s io n
In this study of C. difﬁcile in the food of hospitalized patients,
recovery of toxigenic C. difﬁcile was rare, with only 0.2% of
food specimens testing positive for C. difﬁcile with a low
estimated concentration (≤10 colony-forming units/mL).
Stated differently, 1.5% of patients ingested food from which
C. difﬁcile was recovered. On the basis of this ﬁnding,

NOTE. Percentages are percent of positive samples / all food items of
that type. As patients placed all components of their meal into the
same container, there were multiple types of food per container.
a
The positive specimens for vegetables and bread/grains were
combined in a single specimen cup.
b
For example, veggie burger, sauce/gravy, pudding, jelly, ﬁsh, cake.
c
Gelatin dessert.
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ﬁgure 3. Scatterplots between the hospital-level variables (antibiotic prescription and meal contamination probability) and model
outcomes (number of exposed and colonized patients per 1,000 admissions). The points indicate individual simulations (total number of
simulations = 5,000) and the line indicates the linear trend between variables.

that acquisition of C. difﬁcile from food is likely a rare event at
BJH and that the food of hospitalized patients was not a
signiﬁcant source of new C. difﬁcile colonization.
Most previously published studies of C. difﬁcile in food have
focused on retail meat products, with prevalence rates reported
in Europe and Canada ranging from 2.7% in chicken and
4.3%–20% in beef/pork, and with rates in US studies greater
than 40% (ground meats).8,10–12 The presence of C. difﬁcile in
foods of non-animal origin (eg, fruits, vegetables, grains) has
not been fully explored, with a Scottish study indicating that
7.5% of salads and a French study reporting 2.9% of raw
vegetables were contaminated with C. difﬁcile.6–8 These previous studies were based on singular food types, rather than a
mixture of foods that constitute a meal that a patient might eat.
In our study, we included all food that the patient would be
consuming during that meal, which would better represent a
hospitalized patient’s actual C. difﬁcile exposure.
Although we were able to recover C. difﬁcile from the food of
hospitalized patients, this does not equate directly to C. difﬁcile
being a foodborne pathogen in the healthcare setting.
The source of contamination is not known; contamination
may have occurred at the food source (farm, factory), food
handler, food transporter, and/or from the patient handling

the food. The results of our study are consistent with those of
Rodriguez et al,13 who found C. difﬁcile in less than 1% of food
samples collected from the kitchens of a Belgian nursing home.
C. difﬁcile was isolated from only one meal sample composed
of pork sausage, mustard sauce, and carrot salad.13 Together,
our study and the Rodriquez study suggest that C. difﬁcile is
present in hospital foods but at lower rates compared with
retail foods. The reason for this discrepancy is unclear.
Although C. difﬁcile spores can survive cooking temperatures,
it is possible that soaking, washing, and/or cooking food
reduces the C. difﬁcile burden and may have accounted for this
difference.10
This study had limitations: it was a single-center study, and
results may not be generalizable to all institutions. Regarding
specimen collection, patients placed food into containers for
culture, potentially introducing variability. However, this
provided a practical method of obtaining food samples that
were actually consumed by the patient. There are no data
available to indicate whether or not C. difﬁcile is evenly
distributed in food. Thus the amount of food included in each
food culture may have impacted our ﬁndings, especially in the
setting of a low contamination burden. In previously
published studies the amount of food cultured varies widely,
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from 1 g samples to complete pieces of meat.14,17 Previous
studies were limited to speciﬁc food types; however, this study
focused on the variety of foods that a patient ingests per meal,
providing a more realistic estimate of a patient’s entire meal.
A strength of our study was the collection of food that was
actually consumed, rather than a single food type. In the studies of retail food products, the food would have likely been
washed and/or cooked prior to consumption; therefore the
prevalence of C. difﬁcile detected may not represent what
individuals would have consumed. Additional strengths
include the collection of clinical data to examine CDI in the
year after enrollment and culture of food specimens along with
the culture of stool specimens throughout the patients’
hospitalizations. This allowed us to link C. difﬁcile food contamination with acquisition. Our laboratory standards were
rigorous, and we included both positive and negative controls
to ensure against laboratory contamination.
C. difﬁcile is a ubiquitous organism, and only a minority of
new C. difﬁcile acquisitions in the hospital have been linked to
another patient with CDI.4,5,30,31 Therefore, understanding all
potential sources of C. difﬁcile exposure in the hospital is
necessary to inform prevention measures for CDI. Our ﬁndings indicate that food is unlikely to be a signiﬁcant source of
C. difﬁcile acquisition in hospitalized patients. Towards the
goal of CDI prevention, future studies aimed at understanding
modes of C. difﬁcile transmission and acquisition are
necessary.
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